iRhythm Technologies Receives European Union's CE Marking Under Medical Device Regulation For Zio Monitor And ZEUS System
Portfolio Pulse from Benzinga Newsdesk
iRhythm Technologies has been granted the CE Mark under the European Union's Medical Device Regulation for its Zio monitor and ZEUS system, allowing the company to market these products in the EU.

January 03, 2024 | 1:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
iRhythm Technologies' receipt of the CE Mark for its Zio monitor and ZEUS system is likely to positively impact its ability to market and sell these products in the European Union.
The CE Mark is a critical regulatory milestone that enables medical device companies to market their products in the European Union. Receiving this certification suggests that iRhythm Technologies' Zio monitor and ZEUS system meet the EU's stringent safety, health, and environmental protection requirements. This development can lead to increased market penetration and revenue growth in the EU, which is positive for the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100